Variables | Control (n = 281) | Poor outcome (n = 124) | P value |
---|---|---|---|
Age(year) | 53.8 ± 13.4 | 55.3 ± 13.5 | 0.371 |
Gender male n (%) | 217 (77.2) | 93 (75.0) | 0.626 |
BMI(kg/m2) | 25.4 (23.3–28.4) | 25.2 (20.9–27.7) | 0.570 |
Medical history n (%) | |||
Hypertension | 271 (96.4) | 116 (93.5) | 0.193 |
Diabetes mellitus | 50 (17.8) | 30 (24.2) | 0.136 |
COPD | 98 (34.9) | 45 (36.3) | 0.784 |
Smoking | 135 (48.0) | 58 (46.8) | 0.814 |
Heavy alcohol drinking | 41 (14.6) | 17 (13.7) | 0.816 |
Liver diseases | 12 (4.3) | 1 (0.8) | 0.068 |
Marfan syndrome | 14 (5.0) | 6 (4.8) | 0.951 |
Cerebral infarction | 12 (4.3) | 5 (4.0) | 0.912 |
Chronic renal failure | 3 (1.1) | 1 (0.8) | 0.806 |
Ascending aortic diameter (cm) | 4.7 (4.4–5.4) | 5.1 (4.5–5.5) | 0.003 |
Pre-operative PCT (ng/ml) | 0.01 (0.01–0.1) | 0.01 (0.01–0.1) | 0.207 |
Pre-operative CRP (mg/L) | 3.52 (1.14–7.8) | 3.6 (1.5–6.0) | 0.984 |
Pre-operative IL-6 (pg/ml) | 34.7 (11.9–60.0) | 40 (17.4–61.6) | 0.205 |
Pre-operative SII | 546 (153–1326) | 539 (152–1512) | 0.874 |
Pre-operative Neutrophile (× 109/L) | 4.3 (1–9.2) | 9.2 (4.8–13.0) | 0.822 |
Pre-operative Lymphocyte (× 109/L) | 1.0 (0.7–1.4) | 0.9 (0.8–1.3) | 0.556 |
Pre-operative Platelet (× 109/L) | 155 (116–190) | 153 (121–176) | 0.776 |
Preoperative conditions n (%) | |||
Bowel ischemia | 0 | 7 (5.6) | < 0.001 |
Cerebral ischemia | 0 | 42 (10.4) | < 0.001 |
Limb ischemia | 0 | 51 (41.1) | < 0.001 |
Coronary artery involvement | 7 (2.5) | 6 (4.8) | 0.217 |
Arch surgery n (%) | 0.702 | ||
Total arch replacement | 183 (65.2) | 86 (69.4) | Â |
Hemi arch replacement | 40 (14.2) | 16 (12.9) | Â |
Arch stent | 58 (20.6) | 22 (17.7) | Â |
Root surgery n (%) | 0.304 | ||
Bentall procedure | 144 (51.2) | 65 (52.4) | Â |
Wheat’s procedure | 56 (25.7) | 36 (29.0) |  |
Reconstruction | 81 (23.1) | 23 (18.6) | Â |
Concomitant CABG n (%) | 7 (2.5) | 6 (4.8) | 0.217 |
CPB time (min) | 182 (158.5–220.5) | 188 (163–228) | 0.233 |
ACC time (min) | 133 (110.5–169.0) | 135 (120–175) | 0.099 |
DHCA time (min) | 33 (26–41) | 31 (25–43) | 0.594 |